Opinion

Video

Treatment Options for Patients With Primary or Recurrent Cervical Cancer

Author(s):

Claire Friedman, MD,Emily Davan, RN

Experts on cervical cancer discuss treatment options for patients with primary or recurrent cervical cancer and review the GOG 240 study.

Related Videos
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
A panel of 3 experts on cervical cancer seated on chairs in a studio
A panel of 3 experts on cervical cancer seated on chairs in a studio
Linda Ryan, a patient advocate
A panel of 3 experts on cervical cancer seated on chairs in a studio
A panel of 3 experts on cervical cancer seated on chairs in a studio
A panel of 3 experts on cervical cancer seated on chairs in a studio
A panel of 3 experts on cervical cancer seated on chairs in a studio
A panel of 3 experts on cervical cancer seated on chairs in a studio
A panel of 3 experts on cervical cancer seated on chairs in a studio
Related Content
Illustration of female reproductive system.
September 14th 2024

Keytruda Plus Chemoradiotherapy May Represent New Standard of Care in Cervical Cancer Subset

Kristi Rosa
Patients with previously untreated, high-risk locally advanced cervical cancer experienced improved survival when treated with Keytruda plus chemoradiotherapy.
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
January 22nd 2024

A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

Alex Biese Brielle Benyon
We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.
image of a patient speaking with their doctor.
June 28th 2024

My Rare Cervical Cancer Community

Jezebel Corpuz
Having an unwavering cancer community on Facebook has given me strength, which all started after they sent a teal blanket to me.
Kate Weissman, a gynecologic cancer survivor
November 30th 2023

Fertility Research ‘Long Overdue’ for Patients With Cervical Cancer

Alex Biese
Cervical cancer survivor Kate Weissman talks recent research on follow-up visits for patients after fertility-sparing surgery, and explains why it’s ‘something that the cervical cancer community is owed.’
Image of FDA approved with a checkmark.
April 29th 2024

FDA Approves Tivdak for Metastatic Cervical Cancer

Brielle Benyon
The Food and Drug Administration approved Tivdak for metastatic cervical cancer that progressed on or after chemotherapy.
Image of a doctor holding a sign that says "cervical cancer."
April 8th 2024

Simple Hysterectomy May Be Effective in Low-Risk Cervical Cancer

Alex Biese
Research has found simple hysterectomy to not be inferior to radical hysterectomy among patients with low-risk cervical cancer.